Oral Abstract Presentation Session 1
Tracks
.
| Thursday, October 2, 2025 |
| 1:45 PM - 4:00 PM |
| Room 17 |
Overview
Chairs:
Sara El-Hoss & Thiago Trovati
Presenters
Dr Sara El Hoss
Researcher
Institut Imagine
Session Chair
Mr. Thiago Trovati Maciel
Researcher
Institut Imagine / INSERM
Session Chair
Prof. Jatin Sarmah
Rector
Bodoland University
Vincamine as a Potential Therapeutic Agent for Sickle Cell Disease: An In Silico Study
Dr Wenjie Pang
Chief Scientific Officer
Resonance Health
Liver Iron Measurement Using 3T MRI - Accuracy and Interchangeability Compared with 1.5T MRI
Mrs. Sophia Delicou
Hematolgist
Hippocratio General Hospital ,Expertise Center of Hemoglobinopathies and Their Complications
Growth Differentiation Factor-15 as a Non-Invasive Biomarker of Liver Fibrosis in Sickle Cell Disease
Mr. Lewis Jenkins
Trainee Clinical Scientist
Guy's And St Thomas' Nhs Trust
Paediatric haemoglobinopathies iron chelation audit: Liver iron concentration using R2 vs R2*
Dr Wing Kit Lam
Resident Specialist
Tuen Mun Hospital
All-in-one --SEA, β-thalassaemia and haemoglobinopathy screening through the novel α-thalassaemia early eluting peak
Dr Simona Leoni
Medical Doctor, PhD Student
University of Milan
Impact Of TGF-β Pathway Variants On Luspatercept Response In Transfusion-Dependent Thalassemia
Miss Fatima Oyawoye
Phd Student
University Of Bristol
Generation of Sickle Cell Disease Model Systems Using CRISPR-Cas9 Technology
Dr Minke Rab
Internist-hematologist
Erasmus University Medical Center
Impaired Pyruvate Kinase Correlates With Hemolysis, Ineffective Erythropoiesis, and Endothelial Dysfunction in Sickle Cell Disease
Dr Brid Ryan
Chief Scientific Officer
Mina Therapeutics
Small activating RNA-mediated induction of HBG with liposome delivery for in vivo treatment of SCD
